Launchpad Therapeutics
About:
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Website: http://launchpadtherapeutics.com
Top Investors: Black Diamond Therapeutics, New Enterprise Associates, Versant Ventures
Description:
Launchpad Therapeutics operates as an antibody-focused precision oncology company.
Total Funding Amount:
$40M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2022-01-01
Founders:
Anna Kohlmann, Ken Geles
Number of Employees:
1-10
Last Funding Date:
2022-12-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai